This story is sponsored by UHealth, the University of Miami Health System.
Dr. Teshamae Monteith is a neurologist and chief of the Headache Division at the University of Miami Health System. To learn more about comprehensive migraine care at UHealth or to make an appointment, call 305-243-3100 or visit the University of Miami's health news blog.
For nearly 10 years, Cherise Irons suffered migraines so intense she sometimes blacked out while driving her car. Ultimately, it affected her ability to continue in her role as assistant principal at a Maryland high school.
“It's affecting my sleep. My appetite is going, I'm starting to feel tingling in my fingers and toes. I'm laying on the desk at meetings. I'm not functional at all,” she says, recalling a low point in her battle against migraines.
But Cherise found relief from her migraines at UHealth, the University of Miami Health System, after consulting with migraine expert Dr. Teshamae Monteith. Dr. Monteith is the chief of UHealth’s headache division, a rare find in South Florida.
“There are only so few academic headache programs as well as certified headache specialists within our nation,” she says. “At UHealth, we have a comprehensive center where we have not just our outpatient center but we have an infusion center as well as an inpatient center.”
Through UHealth’s inpatient migraine service, Cherise received a combination of standard IV therapies and medications that are newly available. “We're able to offer treatments that actually have been around for quite a long time, but are unfortunately under-utilized, including intravenous dihydroergotamine, as well as lidocaine and sometimes ketamine infusions,” says Dr. Monteith.
By the third day of her hospital stay, Cherise was relieved of all migraine symptoms. “No pain for me meant no pain in any form at all, so no nerve pain, no kind of tingling, no nothing,” she says.
Cherise’s ongoing treatment includes a new drug for migraine prevention called Fremanazumab, one of three therapies designed specifically to treat migraines with a monthly injection. “Fremanazumab is a monoclonal antibody to CGRP, a protein that is implicated in migraine pathophysiology,” says Dr. Monteith, who played a key role in the research that brought this new drug to market. “Cherise has continued to do really well with this new treatment.”
During the height of her migraine attacks, coffee shops were off limits for Cherise. They were too noisy, and she was not able to interact with others or even focus on her own work in a public space. Now, with more than 150 days without migraines under her belt, Cherise has become a regular at Lady in the Mug, a coffee shop in Coral Springs, Florida, where she socializes and studies for a course she’s taking in ministry.
“There's no ceiling. There's no limit on my life anymore. I get to do what I want, be where I want,” she says.
Cherise continues her treatments at home with monthly injections, a new option for patients. In July 2019, the story of her journey back to health was recognized with an award in the American Migraine Foundation’s annual short film contest.
Although it can be hard to find physicians trained to treat headaches, migraine sufferers should not be discouraged, says Dr. Monteith. UHealth provides a full spectrum of care that includes access to psychologists and support for lifestyle changes that can help prevent migraines.
“If you’re suffering, get help,” says Dr. Monteith. “If you got help and you're disappointed because you didn't have the outcome that you wanted, don't give up because your life is on the line. We have new treatments and new ways of thinking about migraine all the time.”
Focusing On You
Focusing on You: Innovations in Modern Medicine is a series of healthcare-related stories airing regularly on WPLG Local 10. For more stories like this one, visit YouTube channels for UHealth, the University of Miami Health System.
Above content provided by UHealth, the University of Miami Health System.